

Get the latest on the Mannitol/Sorbitol irrigation solution shortage in 2026. Learn about availability, cost, alternatives, and how to find it in stock.
In September 2024, Hurricane Helene slammed into western North Carolina, flooding Baxter International's North Cove manufacturing plant — the facility responsible for producing roughly 60% of America's IV fluids and irrigation solutions. What followed was the worst sterile fluid shortage in recent U.S. history, and its effects are still being felt in 2026.
Mannitol/Sorbitol irrigation solution, a critical fluid used during transurethral and hysteroscopic surgeries, is among the products still affected. Here's what patients need to know right now.
Yes. As of early 2026, Mannitol/Sorbitol irrigation solution remains on allocation from ICU Medical, the sole U.S. manufacturer of the combination product. This means hospitals and surgical centers can only order limited quantities based on their historical purchasing patterns.
The American Society of Health-System Pharmacists (ASHP) continues to list multiple sterile fluid and irrigation products on their current drug shortage list. While the situation has improved significantly from the crisis peak in late 2024, supply has not fully returned to pre-hurricane levels for all products.
Several factors continue to constrain supply:
For a deeper dive, read: Why is Mannitol/Sorbitol so hard to find?
Mannitol/Sorbitol irrigation solution is not a retail pharmacy product — it's a hospital-use surgical supply. Patients don't typically purchase it directly. Instead, the cost is rolled into your surgical facility fees.
For reference, the cash price for Mannitol/Sorbitol irrigation is approximately $61 for a 12,000 mL supply (four 3,000 mL bags). Per bag, that works out to roughly $15–$20. However, during shortages, some distributors may charge premium pricing, and facilities may absorb increased costs that get passed along in overall surgical fees.
The cost is typically covered under:
For tips on managing costs, see: How to save money on Mannitol/Sorbitol in 2026.
While no new manufacturers have entered the Sorbitol-Mannitol combination market, the shortage has accelerated some positive changes:
More hospitals and surgery centers are investing in bipolar resectoscopes, which allow surgeons to use normal saline (0.9% Sodium Chloride) instead of nonelectrolytic solutions like Mannitol/Sorbitol. This shift has been happening for years, but the shortage has given it new urgency. If your facility has bipolar equipment, the Mannitol/Sorbitol shortage may not affect your procedure at all.
Surgeons have adapted by using:
Learn more: Alternatives to Mannitol/Sorbitol.
During the height of the shortage, the FDA authorized emergency measures including extended expiration dates for some IV and irrigation products and temporary importation of products from Canadian manufacturing facilities. Some of these measures may still be in effect in 2026, expanding the available supply.
If your procedure specifically requires Mannitol/Sorbitol, here's how to track it down:
For more detailed tips, read: How to find Mannitol/Sorbitol in stock near you.
The Mannitol/Sorbitol shortage has been an ongoing challenge for hospitals and patients since Hurricane Helene disrupted the IV fluid supply chain in September 2024. While conditions have improved, the product remains on allocation in 2026, and some facilities still experience spot shortages.
The key takeaways for patients:
For a complete overview of this medication, visit: What is Mannitol/Sorbitol?
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.